Streetbeat News

Stock Prices

BDRX

Bioedexa Pharmaceuticals shares are trading lower following the release of patient updates from the MAGIC-1 study of MTX110 in recurrent Glioblastoma, which reported on progression-free survival and overall survival.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:56 pm

VSTM

Verastem's shares are declining following the presentation of updated data on their Avutometinib and Defactinib combination treatment for recurrent low-grade serous ovarian cancer at IGCS 2024.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:53 pm

CMC

Commercial Metals Company (CMC) reported a slight beat on Q4 EPS but missed revenue expectations. The company anticipates a challenging start to fiscal 2025 due to macroeconomic uncertainties and weaker sentiment in the construction industry. Despite stable demand in North America, European operations faced losses. CMC's strategic initiatives aim for long-term value creation.

Portfolio Pulse from Akanksha Bakshi

October 17, 2024 | 1:52 pm

BNTX

GSK

MRNA

PFE

Northwestern University has filed a patent infringement lawsuit against Moderna, alleging unauthorized use of its lipid nanoparticle technology in Moderna's COVID-19 vaccines. This legal action adds to Moderna's ongoing patent disputes, including a recent lawsuit from GSK. Moderna's stock has seen a slight decline following these developments.

Portfolio Pulse from Vandana Singh

October 17, 2024 | 1:51 pm

UPXI

Upexi shares have resumed trading after a temporary halt. This development is crucial for investors monitoring UPXI's stock movements.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:50 pm

VSME

VS Media shares have resumed trading after a temporary halt. This development is significant for investors as it may impact the stock's short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:49 pm

DIA

IWM

QQQ

SPY

TSM

Major indexes rose due to strong performance in chip stocks after TSM's earnings, an ECB rate cut, and better-than-expected US retail sales.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:49 pm

ASPI

ASP Isotopes shares are experiencing an increase following the company's announcement of successful acceleration in enriching Ytterbium-176 using quantum enrichment technology.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:48 pm

LCID

Lucid Group (NASDAQ:LCID) has seen a surge in options activity, with a significant portion of investors adopting a bullish stance. The stock is currently trading at $2.85, down 13.11%, and is considered oversold. Analysts have set an average price target of $3.75, with recent downgrades to Neutral ratings.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 1:47 pm

META

Deep-pocketed investors are showing significant interest in Meta Platforms (NASDAQ:META) options, with a mix of bullish and bearish sentiments. The options activity suggests a potential price window of $545 to $700. Analysts have mixed ratings, with price targets ranging from $525 to $811.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 1:47 pm